Faculty of Pharmaceutical Sciences, Sojo University, Nishi-ku, Kumamoto 860-0082, Japan.
Curr Drug Deliv. 2021;18(8):1121-1129. doi: 10.2174/1567201818666210125111256.
D-Amino acid oxidase (DAO) is an H2O2-generating enzyme, and tumor growth suppression by selective delivery of porcine DAO in tumors via the cytotoxic action of H2O2 has been reported. DAO isolated from Fusariumspp. (fDAO) shows much higher enzyme activity than porcine DAO, although the application of fDAO for antitumor treatment has not yet been determined.
The purpose of this study was to prepare enzymatically highly active pegylated-fDAO, and to determine whether it accumulates in tumors and exerts a potent antitumor effect in tumor- bearing mice.
Polyethylene glycol (PEG; Mw. 2000) was conjugated to fDAO to form PEGylated fDAO (PEG-fDAO). PEG-fDAO was intravenously administered into S180 tumor-bearing mice, and the body distribution and antitumor activity of PEG-fDAO was determined.
The enzyme activity of PEG-fDAO was 26.1 U/mg, which was comparable to that of fDAO. Intravenously administered PEG-fDAO accumulated in tumors with less distribution in normal tissue except in the plasma. Enzyme activity in the tumor was 60-120 mU/g-tissue over 7-20 h after i.v. injection of 0.1 mg of PEG-fDAO. To generate the H2O2 in the tumor tissue, PEG-fDAO was intravenously administered, and then, D-phenylalanine was intraperitoneally administered after a lag time. No remarkable tumor suppression effect was observed under conditions used in this study, compared to the non-treated group.
The results suggest that PEG-fDAO maintained high enzymatic activity after pegylation. Treatment with PEG-fDAO conferred high enzyme activity on tumor tissue; 3-6 fold higher than that of previously reported pDAO; however, high enzyme activity in the plasma limited repeated treatment owing to lethal toxicity, which seemingly led to poor therapeutic outcome. Overall, the use of PEG-fDAO is promising for antitumor therapy, although the suppression of DAO activity in the plasma would also be required rather than only the increase in DAO activity in the tumor for an antitumor effect.
D-氨基酸氧化酶(DAO)是一种产生 H2O2 的酶,通过在肿瘤中选择性输送猪 DAO 并利用 H2O2 的细胞毒性作用已报道了肿瘤生长抑制作用。从镰刀菌属(Fusarium spp.)中分离出的 DAO(fDAO)的酶活性比猪 DAO 高得多,尽管尚未确定 fDAO 在抗肿瘤治疗中的应用。
本研究旨在制备具有高酶活性的聚乙二醇化 fDAO,并确定其是否在肿瘤中积累并在荷瘤小鼠中发挥强大的抗肿瘤作用。
将聚乙二醇(PEG;Mw. 2000)与 fDAO 缀合形成聚乙二醇化 fDAO(PEG-fDAO)。将 PEG-fDAO 静脉内给予 S180 荷瘤小鼠,测定其体内分布和抗肿瘤活性。
PEG-fDAO 的酶活性为 26.1 U/mg,与 fDAO 相当。静脉内给予 PEG-fDAO 后,肿瘤内的分布较少,除血浆外,正常组织中的分布较少。在静脉注射 0.1 mg PEG-fDAO 后 7-20 h,肿瘤中的酶活性为 60-120 mU/g-组织。为了在肿瘤组织中产生 H2O2,静脉内给予 PEG-fDAO,然后在延迟一段时间后腹腔内给予 D-苯丙氨酸。与未治疗组相比,在本研究中使用的条件下,未观察到明显的肿瘤抑制作用。
结果表明,PEG-fDAO 经聚乙二醇化修饰后保持高酶活性。用 PEG-fDAO 处理可使肿瘤组织获得高酶活性;比先前报道的 pDAO 高 3-6 倍;然而,由于毒性致死,血浆中高酶活性限制了重复治疗,这似乎导致了较差的治疗效果。总的来说,PEG-fDAO 的使用有望用于抗肿瘤治疗,尽管需要抑制血浆中的 DAO 活性,而不仅仅是增加肿瘤中的 DAO 活性才能产生抗肿瘤作用。